Nuclear Imaging of CNS Diseases in Rodent Models

Nuclear imaging provides translational and noninvasive in vivo methodology to reliably quantify pathological changes during disease progression and allows evaluation of therapeutic effects of existing or novel drugs against the disease. This webinar showcases new developments of CNS Discovery Services at Charles River, including new access to a nearby cyclotron particle accelerator that can be used to produce short-lived positron-emitting isotopes suitable for PET imaging. In addition, we will discuss arterial input function (AIF) generation from rodents as a gold standard analysis methodology in PET imaging.

Nach Vereinbarung: Ja
Referent: Frau Ph.D. Tuulia Huhtala
Sprache: Englisch
Themen:
  • Gold
  • Charles River
  • Addition
Mehr über Charles River
Ihr Bowser ist nicht aktuell. Microsoft Internet Explorer 6.0 unterstützt einige Funktionen auf Chemie.DE nicht.